Palo Alto, United States
Omniscope, founded in 2021, is pioneering the convergence of AI and Big Data with Biotechnology to establish the world's largest immune databank. This innovative company is utilizing high-resolution immune cell sequencing coupled with artificial intelligence to accelerate therapy development and diagnostic precision. Positioned in the Health Care sector, Omniscope operates out of the United States, aspiring to shorten the timeline from research to real-world application, with a vision centered on accessible healthcare for all.
Their recent strategic move included a €550.00K grant investment received on 01 February 2024, spearheaded by the European Commission. This funding further solidifies their mission-driven approach, marked by their slogan, "Science is we all." Blending interdisciplinary expertise with cutting-edge technology, Omniscope positions itself as a transformative force in healthcare innovation, driven by a commitment to scientific advancement serving humanity.
